Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Delayed Canadian Securities Exchange Other stock markets 10:41:19 2024-05-06 EDT			5-day change	1st Jan Change
0.165 ^CAD	-23.26%		-23.26%	+65.00%

04-29	Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024	CI
04-18	Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding	CI

Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2023

April 28, 2023 at 06:50 pm

Entheon Biomedical Corp. reported earnings results for the first quarter ended February 28, 2023. For the first quarter, the company reported revenue was CAD 0.12 million.

Net loss was CAD 0.095589 million compared to CAD 1.87 million a year ago.

Latest news about Entheon Biomedical Corp.

Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024	04-29	CI
Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding	04-17	CI
Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding	04-10	CI
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2023	03-25	CI
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	23-10-25	CI
Entheon Biomedical Corp. Announces Termination of Andrew Hegle as Chief Science Officer	23-07-31	CI
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	23-07-26	CI
Heading Health Inc. announced that it has received $4.5 million in funding from a group of investors	23-06-28	CI
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2023	23-04-28	CI
Entheon Biomedical Corp. Announces Termination of Consulting Agreement with Cybin	23-04-28	CI
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt	23-03-22	CI
Entheon Biomedical Corp. Announces Resignation of Ruth Chun as Director	23-03-02	CI
Entheon Biomedical Corp. Announces CFO Changes	23-01-05	CI
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022	22-10-31	CI
Entheon Biomedical Corp. Closes Patient Enrolment in its Clinical Research Study EBIQ-101	22-10-05	CI
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022	22-07-26	CI
Entheon Biomedical Corp. cancelled the transaction announced on April 5, 2022	22-06-06	CI
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2022	22-04-29	CI
Entheon Biomedical Corp. announced that it expects to receive CAD 3 million in funding	22-04-04	CI
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2021	22-03-30	CI
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt	22-03-29	CI
Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel, New Clinical Research Platform	22-03-29	MT
Entheon Biomedical Corp. Announces Enrollment in Phase 1 Study of DMT	22-03-15	CI
Entheon Biomedical Corp. Announces EBIQ-101 First-Patient Dose	22-02-24	CI
Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study	22-02-16	CI

Chart Entheon Biomedical Corp.

Duration

Period

More charts

Company Profile

Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is focused on treating addiction and substance-use disorders.

Sector

Biotechnology & Medical Research

Calendar

2024-07-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ENTHEON BIOMEDICAL CORP.	+65.00%	1.07M
MODERNA, INC.	+22.57%	44.96B
IQVIA HOLDINGS INC.	+0.82%	42.65B
LONZA GROUP AG	+46.00%	41.85B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+10.72%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-20.55%	19.03B
BIO-TECHNE CORPORATION	+5.31%	12.75B
MEDPACE HOLDINGS, INC.	+27.30%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.98%	11.75B

Other Biotechnology & Medical Research